Article History
Received: 29 May 2023
Accepted: 30 May 2023
First Online: 15 June 2023
Conflicts of interest
: PP received fees for a lecture from Gilead, Pfizer and Mundipharma, consulting from MSD and Sanofi, and an unrestricted research grant from Abionic. IML fees for lectures from MSD, Gilead, and Mundipharma. SN received fees for lectures from MSD, Pfizer, Gilead, Biomérieux, BioRad, and Fisher and Paykel.